Aditxt shares surge 11.51% intraday after expanding ATM offering capacity by $36.8 million to raise total potential to $53.39 million.

Aditxt surged 11.51% intraday following announcements that expanded its at-the-market (ATM) equity offering capacity by $36.8 million, increasing the total potential offering size to $53,398,964. The move, supported by a prospectus supplement and legal opinion, signals the company's ongoing capital-raising efforts to strengthen its financial position. In addition, Aditxt announced the $36 million acquisition of Ignite Proteomics, a precision oncology firm, which is expected to bolster its oncology initiatives and expand its market presence. These developments suggest a strategic push to grow its business and improve compliance with Nasdaq listing rules, likely contributing to the intraday price increase.